Bioactivity:

VX-702 is a highly specific p38_ MAPK inhibitor, 14-fold higher selectivity for the p38_ than p38_. VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA).

CAS nr:

745833-23-2

Purity:

98%

Molecular Weight:

404,3

SMILES:

c1cc(c(c(c1)F)N(c1nc(c(cc1)C(=O)N)c1c(cc(cc1)F)F)C(=O)N)F

Formula:

C19H12F4N4O2

Pathway:

MAPK,Autophagy

Target:

p38 MAPK,Autophagy